Patients should be at the center and included when it comes to medical decisions and research that relies on their participation. This was main topic of the 2024 Society of Medical Decision Making Conference...
Read More
Can you visualize the main steps that a drug follows from clinical trials to market approval and a successful launch? Don’t forget the twists, turns, and roadblocks—it’s a long road. And if it includes international destinations, bumps and stops are unavoidable. At Bazis Americas, we support...
Read More
The Bazis Americas team was excited to be a part of the 2024 Intellus Fall Institute and participate in the conference for healthcare marketing research. The conference tagline, “Where Great Minds Meet!” was fitting as brilliant minds from across the industry came together to share...
Read More
In our madly connected world, how do you ensure your organization's message resonates with diverse audiences? For health-focused organizations, such as health systems, HMOs, academic medical centers, where trust and clarity are critical, getting your community engagement communication right can make all the difference. This...
Read More
Originally published on LinkedIn on June 6, 2024 Have you ever noticed just how strong the effect of a regular sleep schedule is on your mood and executive functioning? Have you ever successfully managed to change some of your food habits and seen an impact on...
Read More
Anna ShevalovaOriginally published on LinkedIn on February 28, 2024 As we approach Rare Disease Day, celebrated annually on the last day of February, it's crucial to spotlight innovative tools that can transform the patient care experience. One such tool is the Decision Aid, a potentially game-changing...
Read More
Our research shows that students with special needs aspire to more creative and challenging professions than what school administrators would recommend. Which job will be interesting, AND pay well? Every high school graduate is contemplating this question. And if the student has physical or mental limitations or special needs,...
Read More
August is Spinal muscular atrophy (SMA) awareness month. Do you know what SMA is? It is a progressive genetic neuromuscular disorder which is most common among other rare diseasesis currently incurable limits physical abilitiesdoes not affect intelligencemakes patients to be fully dependent on their familiesis carried by...
Read More
The Bazis team was thrilled to take part in a crucial international event in the healthcare marketing research world, the Intellus Summit 2022. Bazis members, Anna Shevalova, Archana Ramakrishna, and Ekaterina Nemenko presented our findings from ongoing research we've done in parent communities and the...
Read More
Zolgensma, a drug used to treat spinal muscular atrophy, has been registered in Russia. Additionally, the age limits for its usage will be extended. Up to now, Zolgensma is the most expensive drug for one-injection treatment that costs $2.1 to $2.5 million and is included...
Read More